[1] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[2] |
LIU CR, LI YP, LUO S, et al. Influencing factors for the short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(1): 56-62. DOI: 10.3969/j.issn.1001-5256.2021.01.012.
刘晨瑞, 李亚萍, 罗森, 等. HBV相关慢加急性肝衰竭患者短期预后的影响因素分析[J]. 临床肝胆病杂志, 2021, 37(1): 56-62. DOI: 10.3969/j.issn.1001-5256.2021.01.012.
|
[3] |
XU J, HUANG M. Predictive value of plasma diamine oxidase concentration combined with iMELD score on short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J/CD]. Chin J Liver Dis (Electronic Version), 2020, 12(2): 68-75. DOI: 10.3969/j.issn.1674-7380.2020.02.012.
许俊, 黄敏. 血浆二胺氧化酶联合iMELD评分对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的预测价值[J/CD]. 中国肝脏病杂志(电子版), 2020, 12(2): 68-75. DOI: 10.3969/j.issn.1674-7380.2020.02.012.
|
[4] |
LI ZL, TONG XJ, TIAN WW, et al. Expression and clinical significance of interleukin 26 in patients with hepatitis B virus related acute-on-chronic liver failure[J]. Clin J Med Offic, 2020, 48(12): 1492-1493, 1496. DOI: 10.16680/j.1671-3826.2020.12.39.
李增莲, 仝晓净, 田稳稳, 等. 白细胞介素26在乙型肝炎病毒相关慢加急性肝衰竭患者中表达及临床意义[J]. 临床军医杂志, 2020, 48(12): 1492-1493, 1496. DOI: 10.16680/j.1671-3826.2020.12.39.
|
[5] |
PIANTANIDA E, IPPOLITO S, GALLO D, et al. The interplay between thyroid and liver: Implications for clinical practice[J]. J Endocrinol Invest, 2020, 43(7): 885-899. DOI: 10.1007/s40618-020-01208-6.
|
[6] |
KAN YT, YANG YF. Serum thyroid hormones in acute on chronic liver failure patients and its correlation with prognosis[J]. Chin Hepatol, 2018, 23(4): 305-306. DOI: 10.3969/j.issn.1008-1704.2018.04.009.
阚延婷, 杨永峰. 慢加急性肝衰竭患者血清甲状腺激素水平变化及其与预后的关系[J]. 肝脏, 2018, 23(4): 305-306. DOI: 10.3969/j.issn.1008-1704.2018.04.009.
|
[7] |
ZHAO WM, DONG PL, FAN CL, et al. The clinical value of thyroid function in patients with acute-on-chronic liver failure[J]. Beijing Med J, 2020, 42(6): 554-556. DOI: 10.15932/j.0253-9713.2020.06.018.
赵文敏, 董培玲, 范春蕾, 等. 慢加急(亚急)肝衰竭患者甲状腺功能变化及临床意义[J]. 北京医学, 2020, 42(6): 554-556. DOI: 10.15932/j.0253-9713.2020.06.018.
|
[8] |
Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
中华医学会感染病学分会, 中华医学会肝病学分. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
|
[9] |
BLEI AT, CÓRDOBA J. Hepatic encephalopathy[J]. Am J Gastroenterol, 2001, 96(7): 1968-1976. DOI: 10.1111/j.1572-0241.2001.03964.x.
|
[10] |
CHANG ML, LIAW YF. Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management[J]. J Hepatol, 2014, 61(6): 1407-1417. DOI: 10.1016/j.jhep.2014.08.033.
|
[11] |
ANGELI P, GINÈS P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites[J]. J Hepatol, 2015, 62(4): 968-974. DOI: 10.1016/j.jhep.2014.12.029.
|
[12] |
Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association. Expert consensus on diagnosis and treatment of esophagogastric variceal bleeding in cirrhotic portal hypertension (2019 edition)[J]. Chin J Surg, 2019, 57(12): 885-892. DOI: 10.3760/cma.j.issn.0529-5815.2019.12.002.
中华医学会外科学分会脾及门静脉高压外科学组. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]. 中华外科杂志, 2019, 57(12): 885-892. DOI: 10.3760/cma.j.issn.0529-5815.2019.12.002.
|
[13] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
|
[14] |
Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol, 2015, 31(11): 1752-1769. DOI: 10.3969/j.issn.1001-5256.2015.11.002.
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 临床肝胆病杂志, 2015, 31(11): 1752-1769. DOI: 10.3969/j.issn.1001-5256.2015.11.002.
|
[15] |
FERNANDO SM, ROCHWERG B, SEELY A. Clinical implications of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. CMAJ, 2018, 190(36): E1058-E1059. DOI: 10.1503/cmaj.170149.
|
[16] |
Chinese Society of Respirology, Chinese Medical Association. Guidelines for the diagnosis and treatment of community- acquired pneumonia in Chinese adults (2016 edition)[J]. Chin J Tuberc Respir Dis, 2016, 39(4): 253-279. DOI: 10.3760/cma.j.issn.1001-0939.2016.04.005.
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279. DOI: 10.3760/cma.j.issn.1001-0939.2016.04.005.
|
[17] |
KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
|
[18] |
LEE S, FARWELL AP. Euthyroid sick syndrome[J]. Compr Physiol, 2016, 6(2): 1071-1080. DOI: 10.1002/cphy.c150017.
|
[19] |
PUNEKAR P, SHARMA AK, JAIN A. A study of thyroid dysfunction in cirrhosis of liver and correlation with severity of liver disease[J]. Indian J Endocrinol Metab, 2018, 22(5): 645-650. DOI: 10.4103/ijem.IJEM_25_18.
|
[20] |
LI Q, WANG J, LU M, et al. Acute-on-chronic liver failure from chronic-hepatitis-B, who is the behind scenes[J]. Front Microbiol, 2020, 11: 583423. DOI: 10.3389/fmicb.2020.583423.
|
[21] |
de LUCA R, DAVIS PJ, LIN HY, et al. Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome[J]. Front Cell Dev Biol, 2020, 8: 614030. DOI: 10.3389/fcell.2020.614030.
|
[22] |
CAI XJ, SHEN Y, ZHU XH, et al. Evaluation of integrated model for end-stage liver disease model in predicting prognosis of acute-on-chronic liver failure and choice of treatment[J/CD]. Chin J Exp Clin Infect Dis(Electronic Edition), 2018, 12(5): 446-452. DOI: 10.3877/cma.j.issn.1674-1358.2018.05.006.
蔡晓娟, 沈毅, 朱晓红, 等. 整合终末期肝病模型在慢加急性肝功能衰竭预后判断及治疗中的应用[J/CD]. 中华实验和临床感染病杂志(电子版), 2018, 12(5): 446-452. DOI: 10.3877/cma.j.issn.1674-1358.2018.05.006.
|
[23] |
ZHANG WJ, ZHAO LJ, WU JZ. Value of MELD、AARC、COSSH scoring systems in evaluating the 90-day prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2020, 36(4): 813-817. DOI: 10.3969/j.issn.1001-5256.2020.04.021.
张文佳, 赵丽娟, 吴基洲. MELD、AARC、COSSH评分系统对乙型肝炎相关慢加急性肝衰竭90天预后的评估价值[J]. 临床肝胆病杂志, 2020, 36(4): 813-817. DOI: 10.3969/j.issn.1001-5256.2020.04.021.
|